Acura Pharma SPRL
0.3 FTEAcura Pharma reported total assets of 366,408 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026), with 0.3 full-time equivalent.
The score of Acura Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +359 % Total assets -45 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Acura Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 69,807 € | ||||
| Equity | 103,540 € | ||||
| Cash | 74,568 € | ||||
| EBITDA | 119,879 € | ||||
| Total assets | 366,408 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 17 Jun 2022
Acura Pharma's financial analysis
- Solvency28.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Acura Pharma
Acura Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0468.913.836
- VAT number
- BE0468913836
- Peppol
- Registered · 0208:0468913836 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 28 Dec 1999
- Registered office
- 1020 Brussels
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Acura Pharma (SPRL) has been based in Brussels since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 69,807 € and equity of 103,540 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 28.3%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Acura Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Besonrieux Centre Retail sale of pharmaceutical products La Louvière · balance sheet 377,209 €
- Apotheek Lauweryns Retail sale of pharmaceutical products Sint-Truiden · balance sheet 365,968 €
- Bogest Retail sale of pharmaceutical products Liège · balance sheet 367,587 €
- APO + Retail sale of pharmaceutical products Antwerp · balance sheet 364,448 €
- PHLV Retail sale of pharmaceutical products Bornem · balance sheet 363,992 €
- Omniphar Retail sale of pharmaceutical products Ronse · balance sheet 369,071 €
- La Roue Pharma Retail sale of pharmaceutical products Anderlecht · balance sheet 369,361 €
- Pharbiomed Retail sale of pharmaceutical products Brussels · balance sheet 369,863 €
Frequently asked questions about Acura Pharma
What is the revenue of Acura Pharma?
Acura Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Acura Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0468913836 for Acura Pharma, if the company is VAT-registered. Its company number (CBE) is 0468.913.836.
Where is the registered office of Acura Pharma?
According to the CBE register, the registered office of Acura Pharma is in 1020 Brussels.
What is the equity of Acura Pharma?
At the close of the 2025 financial year, the equity of Acura Pharma amounts to 103,540 €, a solvency of 28.3% of total assets.
How many people work at Acura Pharma?
0.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Acura Pharma?
The register lists 1 active mandates at Acura Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Acura Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →